The latest emerging drugs for the treatment of diabetic cardiomyopathy

Author:

Li Minghao1,Liu Lin1,Zhang Chunyu1,Deng Li2,Zhong Yi1,Liao Bin3,Li Xiuying4,Wan Ying4,Feng Jian1

Affiliation:

1. Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Key Laboratory of Medical Electrophysiology, Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China

2. Department of Rheumatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China

3. Department of Cardiovascular Surgery, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, China

4. Department of Pharmacy, The Affiliated Hospital of Southwest Medical University; Department of Pathophysiology, School of Basic Medical Science, Southwest Medical University, Luzhou, China

Funder

Key Laboratory of medical electrophysiology

Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province; Southwest Medical University

Sichuan Science and Technology Program

Luzhou Municipal Peoples Government-Southwest Medical University Science and Technology Strategic Cooperation

Gulin County People’s Hospital - Affiliated Hospital of Southwest Medical University Science and Technology strategic Cooperation

Hejiang People’s Hospital - Southwest Medical University Science and Technology Strategic Cooperation Project

Medical Foundation

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3